Positioning

Epic can summarize the chart.
UroLumen structures the urology decision.

“Epic has its own AI that can tell me this.” It can summarize what is in the record. UroLumen does something a general, chart-native assistant does not: it turns the same data into a specialty-deep prostate-risk and patient-decision layer. Scores, gaps, and the questions that drive a visit.

Generic EHR AI vs UroLumen

Generic EHR / Epic AI

UroLumen

Summarizes what is already in the chart.

Structures urology-specific risk from the same data: CAPRA, PSA density, PI-RADS and grade in one framework.

Chart-native. Built around the record and the encounter.

Patient + specialist workflow-native. Built around the prostate-risk decision and the visit.

Tells you what happened.

Helps prepare what to ask, what is missing, and which risk framework applies.

Broad. One assistant across every specialty.

Deep in urology. Opinionated about prostate-cancer and elevated-PSA pathways.

What UroLumen adds out of the box

Validated risk scores

UCSF-CAPRA and PSA density computed deterministically, with an explainable per-factor breakdown. Not a paragraph summary.

Longitudinal risk picture

PSA trend, MRI, biopsy, grade and stage assembled across time into one dashboard, with completeness scoring.

Missing-data intelligence

Surfaces the specific items needed to complete a risk picture, instead of silently summarizing whatever is present.

Doctor-ready visit brief

A printable one-pager a patient brings to the visit: timeline, scores, gaps, decision points and questions.

Patient-education layer

Every score carries clinician language and plain-English, plus what it means and what to ask.

Governed by design

The AI workspace strips identifiers before any model and signs each result. Auditable, not a black box.

The one-line version

Epic AI tells you what happened. UroLumen helps you decide what to ask, what is missing, and which risk framework applies. In urology.

→ See the Risk Dashboard View a Visit Brief

UroLumen is clinical decision support that provides risk structuring and discussion guidance. It is not a diagnostic device, not FDA-cleared, and does not replace physician judgment. Final decisions require a licensed clinician.